Effect of Ghrelin and Thyrotropin-releasing Hormone on Prolactin Secretion in Normal Women

Abstract

It is known that ghrelin stimulates the secretion of prolactin in women. The aim of this study was to examine the effect of exogenous thyrotropin-releasing hormone (TRH) on ghrelin-induced prolactin release. Ten healthy normally cycling women were studied in four menstrual cycles. The women were injected intravenously in late follicular phase (follicle size 16–17 mm) with a single dose of normal saline (cycle 1), ghrelin (1 μg/kg) (cycle 2), thyrotropin-releasing hormone (200 μg) (cycle 3), and ghrelin plus thyrotropin-releasing hormone (cycle 4). Blood samples in relation to saline or drugs injection (time 0) were taken at −15, 0, 15, 30, 45, 60, 75, 90, and 120 min. The prolactin and growth hormone responses were assessed. After ghrelin administration (cycles 2 and 4), plasma ghrelin, serum prolactin, and growth hormone levels increased rapidly, peaking at 15–30 min (p<0.001). The injection of thyrotropin-releasing hormone (cycle 3) stimulated prolactin secretion markedly (p<0.001), but reduced growth hormone levels significantly (p<0.05). Ghrelin induced a smaller prolactin increase than thyrotropin-releasing hormone (p<0.05). The combination of ghrelin and thyrotropin-releasing hormone induced a similar increase in prolactin levels as with thyrotropin-releasing hormone alone. No changes in growth hormone and prolactin levels were seen after saline injection. These results demonstrate that the stimulating effect of ghrelin on prolactin secretion is not additive with that of thyrotropin-releasing hormone.

Key words

ghrelin - TRH - PRL - GH - women

References

• 1 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
• 2 Soares JB, Leite-Moreira AF. Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle.  Peptides. 2008;  29 1255-1270
• 3 Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K. Ghrelin strongly stimulates growth hormone release in humans.  J Clin Endocrinol Metab. 2000;  85 4908-4911
• 4 Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans.  J Clin Endocrinol Metab. 2001;  86 4552-4555
• 5 Villa P, Costantini B, Perri C, Suriano R, Ricciardi L, Lanzone A. Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women.  Fertil Steril. 2008;  89 398-403
• 6 Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle.  Hum Reprod. 2009;  24 976-981
• 7 Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Growth hormone and prolactin response to ghrelin during the normal menstrual cycle.  Clin Endocrinol. 2009;  71 383-387
• 8 Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a non-natural peptidyl GHS, and GH-releasing hormone.  J Clin Endocrinol Metab. 2001;  86 1169-1174
• 9 Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls.  Neuropsychopharmacology. 2005;  30 1187-1192
• 10 Fusco A, Bianchi A, Mancini A, Milardi D, Giampietro A, Cimino V, Porcelli T, Romualdi D, Guido M, Lanzone A, Pontecorvi A, De Marinis L. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.  J Endocrinol Invest. 2007;  30 948-956
• 11 Broglio F, Gianotti L, Destefanis S, Fassino S, Abbate Daga G, Mondelli V, Lanfranco F, Gottero C, Gauna C, Hofland L, Van der Lely AJ, Ghigo E. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.  Clin Endocrinol. 2004;  60 592-599
• 12 Fassino S, Daga GA, Mondelli V, Piero A, Broglio F, Picu A, Giordano R, Baldi M, Arvat E, Ghigo E, Gianotti L. Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa.  Psychoneuroendocrinology. 2005;  30 534-540
• 13 Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.  Clin Endocrinol. 2004;  61 250-255
• 14 Guido M, Romualdi D, De Marinis L, Porcelli T, Giuliani M, Costantini B, Lanzone A. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: Effects on plasma levels of growth hormone, glucose, and insulin.  Fertil Steril. 2007;  88 125-130
• 15 Kok P, Paulo RC, Cosma M, Mielke KL, Miles JM, Bowers CY, Veldhuis JD. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women.  J Clin Endocrinol Metab. 2008;  93 4020-4026
• 16 Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Anifandis G, Messinis IE. Blockage of ghrelin-induced prolactin secretion in women by bromocriptine.  Fertil Steril. in press 
• 17 Hirvonen E, Ranta T, Seppala M. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: The effect of bromocriptine.  J Clin Endocrinol Metab. 1976;  42 1024-1030
• 18 Andreassen B, Huth J, Tyson JE. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.  Am J Obstet Gynecol. 1979;  135 737-742
• 19 Kauppila A, Ylikorkala O. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women.  Clin Endocrinol. 1982;  17 617-623
• 20 Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. A prolactin-releasing peptide in the brain.  Nature. 1998;  393 272-276
• 21 Lin SH. Prolactin-releasing peptide.  Res Prob Cell Differentiation. 2008;  46 57-88
• 22 Sawin CT, Hershman JM, Boyd AE 3rd , Longcope C, Bacharach P. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.  J Clin Endocrinol Metab.. 1978;  47 1296-1302
• 23 Hanew K, Utsumi A, Sugawara A, Shimizu Y, Yoshinaga K. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.  Acta Endocrinol (Copenh). 1991;  124 545-552
• 24 Garbutt JC, Mayo JP, Little KY, Gillette GM, Mason GA, Dew B, Prange Jr. AJ. Dose-response studies with thyrotropin-releasing hormone: evidence for differential pituitary responses in men with major depression, alcoholism, or no psychopathology.  Alcohol Clin Exp Res.. 1996;  20 717-722
• 25 Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.  J Clin Endocrinol Metab. 2006;  91 3559-3565
• 26 Guerineau NC, Lledo PM, Verrier D, Israel JM. Evidence that TRH controls prolactin release from rat lactotrophs by stimulating a calcium influx.  Cell Biol Toxicol. 1994;  10 311-316
• 27 Carew MA, Mason WT. Control of Ca2+ entry into rat lactotrophs by thyrotrophin-releasing hormone.  J Physiol. 1995;  486 349-360
• 28 Yamazaki M, Kobayashi H, Tanaka T, Kangawa K, Inoue K, Sakai T. Ghrelin-induced growth hormone release from isolated rat anterior pituitary cells depends on intracellullar and extracellular Ca2+ sources.  Neuroendocrinology. 2004;  16 825-831
• 29 Faglia G, Beck-Peccoz P, Ferrari C, Travaglini P, Ambrosi B, Spada A. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.  J Clin Endocrinol Metab. 1973;  36 1259-1262
• 30 Panerai AE, Salerno F, Manneschi M, Cocchi D, Muller EE. Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease.  J Clin Endocrinol Metab. 1977;  45 134-140
• 31 Sack J, Shafrir Y, Urbach D, Amado O. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.  Pediatr Res. 1985;  19 1037-1039
• 32 Kaltsas T, Pontikides N, Krassas GE, Seferiadis K, Lolis D, Messinis IE. Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome.  Hum Reprod. 1999;  14 2704-2708
• 33 Zanoboni A, Gibillini M, Cucchi MR, Zanoboni Muciaccia W, Zanussi C. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.  J Endocrinol Invest. 1988;  11 413-417
• 34 Sawin CT, Hershman JM, Boyd AE 3rd , Longcope C, Bacharach P. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.  J Clin Endocrinol Metab. 1978;  47 1296-1302
• 35 Colon JM, Lessing JB, Yavetz C, Peyser MR, Ganguly M, Weiss G. The effect of thyrotropin-releasing hormone stimulation on serum levels of gonadotropins in women during the follicular and luteal phases of the menstrual cycle.  Fertil Steril. 1988;  49 809-812

Correspondence